Literature DB >> 33470415

High Expression of Lactate Dehydrogenase A is a Potential Promoter of Malignant Behaviour in Extramammary Paget's Disease.

Kohei Ogawa1, Keiji Shimada, Toshihiro Takai, Yasuhiro Mitsui, Masamitsu Kuwahara, Hideo Asada.   

Abstract

Entities:  

Keywords:  glycolysis; lactate dehydrogenase A; extramammary Paget’s disease

Mesh：

Substances：

Year:  2021        PMID： 33470415      PMCID： PMC9309856          DOI： 10.2340/00015555-3744

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN： 0001-5555            Impact factor:   3.875


× No keyword cloud information.
  10 in total

1.  Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase.

Authors:  J A Read; V J Winter; C M Eszes; R B Sessions; R L Brady
Journal:  Proteins       Date:  2001-05-01

Review 2.  Targeting lactate metabolism for cancer therapeutics.

Authors:  Joanne R Doherty; John L Cleveland
Journal:  J Clin Invest       Date:  2013-09-03       Impact factor: 14.808

3.  High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers.

Authors:  S Walenta; M Wetterling; M Lehrke; G Schwickert; K Sundfør; E K Rofstad; W Mueller-Klieser
Journal:  Cancer Res       Date:  2000-02-15       Impact factor: 12.701

4.  Letrozole is more effective neoadjuvant endocrine therapy than tamoxifen for ErbB-1- and/or ErbB-2-positive, estrogen receptor-positive primary breast cancer: evidence from a phase III randomized trial.

Authors:  M J Ellis; A Coop; B Singh; L Mauriac; A Llombert-Cussac; F Jänicke; W R Miller; D B Evans; M Dugan; C Brady; E Quebe-Fehling; M Borgs
Journal:  J Clin Oncol       Date:  2001-09-15       Impact factor: 44.544

5.  Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer.

Authors:  J M Harvey; G M Clark; C K Osborne; D C Allred
Journal:  J Clin Oncol       Date:  1999-05       Impact factor: 44.544

Review 6.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

7.  Lactate Dehydrogenase (LDH) Response to First-Line Treatment Predicts Survival in Metastatic Breast Cancer: First Clues for A Cost-Effective and Dynamic Biomarker.

Authors:  Giacomo Pelizzari; Debora Basile; Silvia Zago; Camilla Lisanti; Michele Bartoletti; Lucia Bortot; Maria Grazia Vitale; Valentina Fanotto; Serena Barban; Marika Cinausero; Marta Bonotto; Lorenzo Gerratana; Mauro Mansutti; Francesco Curcio; Gianpiero Fasola; Alessandro Marco Minisini; Fabio Puglisi
Journal:  Cancers (Basel)       Date:  2019-08-24       Impact factor: 6.639

8.  The Warburg effect and tumour immune microenvironment in extramammary Paget's disease: overexpression of lactate dehydrogenase A correlates with immune resistance.

Authors:  K Urata; I Kajihara; H Miyauchi; T Mijiddorj; S Otsuka-Maeda; R Sakamoto; S Sawamura; H Kanemaru; S Kanazawa-Yamada; K Makino; J Aoi; T Makino; S Fukushima; Y Komohara; H Ihn
Journal:  J Eur Acad Dermatol Venereol       Date:  2020-01-22       Impact factor: 6.166

Review 9.  Targeting cellular metabolism to improve cancer therapeutics.

Authors:  Y Zhao; E B Butler; M Tan
Journal:  Cell Death Dis       Date:  2013-03-07       Impact factor: 8.469

10.  Targeting metabolism to induce cell death in cancer cells and cancer stem cells.

Authors:  Claire Pecqueur; Lisa Oliver; Kristell Oizel; Lisenn Lalier; François M Vallette
Journal:  Int J Cell Biol       Date:  2013-02-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.